GB0208331D0 - Proteins - Google Patents
ProteinsInfo
- Publication number
- GB0208331D0 GB0208331D0 GB0208331A GB0208331A GB0208331D0 GB 0208331 D0 GB0208331 D0 GB 0208331D0 GB 0208331 A GB0208331 A GB 0208331A GB 0208331 A GB0208331 A GB 0208331A GB 0208331 D0 GB0208331 D0 GB 0208331D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0208331A GB0208331D0 (en) | 2002-04-11 | 2002-04-11 | Proteins |
US10/510,507 US20050282165A1 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of Carcinoma Using RAIG1 Polypeptides |
DE60310059T DE60310059T2 (en) | 2002-04-11 | 2003-04-10 | DIAGNOSIS OF CARCINOMA WITH THE HELP OF RAIG1 POLYPEPTIDE |
PCT/GB2003/001559 WO2003087831A2 (en) | 2002-04-11 | 2003-04-10 | Proteins involved in breast cancer |
AT03717443T ATE347106T1 (en) | 2002-04-11 | 2003-04-10 | DIAGNOSIS OF CARCINOMA USING THE RAIG1 POLYPEPTIDE |
ES03717443T ES2274220T3 (en) | 2002-04-11 | 2003-04-10 | CARCINOMA DIAGNOSIS USING RAIG1 POLYPEPTIDES. |
JP2003584724A JP2005522226A (en) | 2002-04-11 | 2003-04-10 | Proteins involved in cancer |
PCT/GB2003/001587 WO2003087832A2 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of carcinoma using raigi polypeptides |
AU2003222606A AU2003222606A1 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of carcinoma using raigi polypeptides |
EP03717443A EP1497656B1 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of carcinoma using raig1 polypeptides |
AU2003222604A AU2003222604A1 (en) | 2002-04-11 | 2003-04-10 | Proteins involved in breast cancer |
US11/986,786 US20090258019A1 (en) | 2002-04-11 | 2007-11-26 | Diagnosis of carcinoma using RAIG1 polypeptides |
JP2009284846A JP2010117358A (en) | 2002-04-11 | 2009-12-16 | Protein involved in cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0208331A GB0208331D0 (en) | 2002-04-11 | 2002-04-11 | Proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0208331D0 true GB0208331D0 (en) | 2002-05-22 |
Family
ID=9934645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0208331A Ceased GB0208331D0 (en) | 2002-04-11 | 2002-04-11 | Proteins |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003222604A1 (en) |
GB (1) | GB0208331D0 (en) |
WO (1) | WO2003087831A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005124357A1 (en) * | 2004-06-18 | 2005-12-29 | Roche Diagnostics Gmbh | Use of protein elongation factor-1-alpha-1 as a marker for breast cancer |
US7807789B2 (en) * | 2004-12-21 | 2010-10-05 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in EGFR-signaling pathways |
WO2006116541A2 (en) * | 2005-04-27 | 2006-11-02 | Caprion Pharmaceuticals, Inc. | Tat-002 and methods of assessing and treating cancer |
GB0520067D0 (en) * | 2005-10-01 | 2005-11-09 | Cancer Rec Tech Ltd | Treatment of cancer |
GB0611116D0 (en) * | 2006-06-06 | 2006-07-19 | Oxford Genome Sciences Uk Ltd | Proteins |
WO2008005556A2 (en) * | 2006-07-07 | 2008-01-10 | 9183-4663 Quebec Incorporated | Tat-048 and methods of assessing and treating cancer |
GB0621279D0 (en) * | 2006-10-26 | 2006-12-06 | Nat Blood Service | Binding site |
FR2919064B1 (en) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF ASSAYING APOLIPOPROTEIN ALL FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
FR2919061B1 (en) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DOSING PLASTINE-I FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
FR2919060B1 (en) * | 2007-07-19 | 2012-11-30 | Biomerieux Sa | METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
EP2171467B1 (en) | 2007-07-19 | 2016-01-13 | bioMérieux | Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer |
FR2919065B1 (en) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
FR2919062B1 (en) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DETERMINING AMINOACYLASE 1 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
FR2919063B1 (en) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
AU2008329529B2 (en) * | 2007-11-27 | 2015-02-19 | The University Of British Columbia | 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
FR2933773B1 (en) | 2008-07-10 | 2013-02-15 | Biomerieux Sa | METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
FR2940125B1 (en) | 2008-12-23 | 2013-03-22 | Isp Investments Inc | COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE |
FR2940291B1 (en) * | 2008-12-23 | 2012-12-21 | Isp Investments Inc | PEPTIDE DERIVED FROM HMG-COA REDUCTASE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
ES2714216T3 (en) | 2009-03-11 | 2019-05-27 | Augurex Life Sciences Corp | Compositions and methods to characterize arthritic conditions |
US8933036B2 (en) | 2009-04-15 | 2015-01-13 | Isp Investments Inc. | Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair |
FR2944526B1 (en) | 2009-04-15 | 2013-05-10 | Isp Investments Inc | COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE HYDROLYZATE CAPABLE OF STRENGTHENING BARRIER FUNCTION |
FR2944445B1 (en) | 2009-04-15 | 2013-08-16 | Isp Investments Inc | COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A SOOTHING PEPTIDE HYDROLYZATE |
DK3144394T3 (en) * | 2010-12-08 | 2019-05-13 | Expression Pathology Inc | SRM / MRM test for the truncated HER2 |
EP2768851B1 (en) | 2011-10-21 | 2017-05-31 | Augurex Life Sciences Corporation | Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
ES2526468B2 (en) * | 2013-06-07 | 2015-08-07 | Universidad Complutense De Madrid | Method of selection of specific antibodies of European hake (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin. |
GB201520546D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
WO2017100663A1 (en) | 2015-12-09 | 2017-06-15 | Expression Pathology, Inc. | Improved methods for treating her2-positive breast cancer |
IT202000016807A1 (en) * | 2020-07-10 | 2022-01-10 | Humanitas Mirasole Spa | PEPTIDES ASSOCIATED WITH CANCER AND THEIR USE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS626169A (en) * | 1985-07-03 | 1987-01-13 | Mochida Pharmaceut Co Ltd | Reagent for diagnosing cancer |
GB0004576D0 (en) * | 2000-02-25 | 2000-04-19 | Oxford Glycosciences Uk Ltd | Proteins |
DE60126248T2 (en) * | 2000-02-25 | 2007-07-05 | Ucb S.A. | USE OF BREAST CANCER MEMBRANE PROTEINS FOR TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BREAST CANCER |
-
2002
- 2002-04-11 GB GB0208331A patent/GB0208331D0/en not_active Ceased
-
2003
- 2003-04-10 AU AU2003222604A patent/AU2003222604A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001559 patent/WO2003087831A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003222604A1 (en) | 2003-10-27 |
WO2003087831A3 (en) | 2004-07-29 |
AU2003222604A8 (en) | 2003-10-27 |
WO2003087831A2 (en) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0208331D0 (en) | Proteins | |
GB0209884D0 (en) | Proteins | |
GB0220770D0 (en) | Proteins | |
EP1487874A4 (en) | Falp proteins | |
GB0212067D0 (en) | Proteins | |
IL169260A0 (en) | Il-8 -like proteins | |
GB0201808D0 (en) | Protein | |
AU2003270055A8 (en) | Neurotransmission-associated proteins | |
AU2003278718A8 (en) | Stars-a muscle-specification-binding protein | |
AU2003300785A8 (en) | Carbohydrate-associated proteins | |
AU2003295760A8 (en) | Organelle-associated proteins | |
GB0214543D0 (en) | Proteins | |
GB0216757D0 (en) | Proteins | |
GB0202748D0 (en) | Protein | |
GB0221564D0 (en) | Proteins | |
GB0204500D0 (en) | Proteins | |
GB0211903D0 (en) | Proteins | |
GB0217631D0 (en) | Proteins | |
GB0218039D0 (en) | Proteins | |
GB0219053D0 (en) | Proteins | |
GB0220768D0 (en) | Proteins | |
GB0211525D0 (en) | Proteins | |
GB0210440D0 (en) | Proteins | |
GB0221567D0 (en) | Proteins | |
GB0222512D0 (en) | Proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |